1. Genet Res. 2001 Apr;77(2):183-90.
Effects of Dmo1 on obesity, dyslipidaemia and hyperglycaemia in the Otsuka Long
Evans Tokushima Fatty strain.
Okuno S(1), Watanabe TK, Ono T, Oga K, Mizoguchi-Miyakita A, Yamasaki Y, Goto Y,
Shinomiya H, Momota H, Miyao H, Hayashi I, Asai T, Suzuki M, Harada Y, Hishigaki
H, Wakitani S, Takagi T, Nakamura Y, Tanigami A.
Author information:
(1)Otsuka GEN Research Institute, Otsuka Pharmaceutical Co., Ltd, 463-10
Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan.
Whole-genome scans have identified Dmo1 as a major quantitative trait locus (QTL)
for obesity and dyslipidaemia in the Otsuka Long Evans Tokushima Fatty (OLETF)
rat. We have produced congenic rats for the Dmo1 locus, using marker-assisted
speed congenic protocols, enforced by selective removal of other QTL regions
(QTL-marker-assisted counterselection), to efficiently transfer chromosomal
segments from non-diabetic Fischer 344 (F344) rats into the OLETF background. In
the third generation of congenic animals, we observed a substantial therapeutic
effect of the Dmo1 locus on lipid metabolism, obesity control and plasma glucose
homeostasis. We conclude that single-allele correction of an impaired genetic
pathway can generate a substantial therapeutic effect, despite the complex
polygenic nature of type II diabetic syndromes.
PMID: 11355573 [PubMed - indexed for MEDLINE]
PUBMED: 11355573
Find other GeneSets from this publication